Determinants of the Availability of Hepatitis C Testing Services in Opioid Treatment Programs: Results From a National Study

I tiakina i:

Ngā taipitopito rārangi puna kōrero
I whakaputaina i:	American Journal of Public Health vol. 104, no. 6 (Jun 2014), p. E75-E82
Kaituhi matua:	Frimpong, Jemima A
Ētahi atu kaituhi:	D'Aunno, Thomas, Jiang, Lan
I whakaputaina:	American Public Health Association
Ngā marau:	Financing, Government > statistics & numerical data Health Care Surveys Health Services Accessibility > organization & administration Health Services Accessibility > statistics & numerical data Hepatitis C > diagnosis Humans Opiate Substitution Treatment > statistics & numerical data Opioid-Related Disorders > complications Substance Abuse Treatment Centers > organization & administration Substance Abuse Treatment Centers > statistics & numerical data United States United States > US Substance abuse treatment Methadone Drug abuse Hepatitis Medical tests Health care industry Infections Validity Trends Drug use Response rates Disease prevention Mental health Health services Onsite Narcotics Mental health care Public health Opioids Treatment programs Medical treatment Referrals Diagnostic tests Availability Substance abuse Prevention programs Buprenorphine Blood diseases Social
Urunga tuihono:	Citation/Abstract Full Text Full Text - PDF
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Me noho koe te mea tuatahi ki te waiho tākupu!